LONDON--(BUSINESS WIRE)--
Ap19
FORM 8.3 - Amendment to Purchase and Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 12 November 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) |
Relevant securities | ||||
3,251,799 |
2.52% |
686,779 |
0.53% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
366,484 |
0.28% |
739,005 |
0.57% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
| purchase/sell: | 0 |
0.00% |
0 |
0.00% |
|
|
|
|
|
||
| TOTAL: |
|
|
|
|
|
3,618,283 |
2.81% |
1,425,784 |
1.11% |
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase |
17 |
201.8653 USD |
Purchase |
50 |
201.8300 USD |
Purchase |
93 |
202.0700 USD |
Purchase |
237 |
202.5346 USD |
Purchase |
312 |
201.9795 USD |
Purchase |
454 |
201.3423 USD |
Purchase |
542 |
202.0180 USD |
Purchase |
562 |
202.3911 USD |
Purchase |
669 |
202.0743 USD |
Purchase |
714 |
202.2949 USD |
Purchase |
846 |
202.2170 USD |
Purchase |
1,214 |
202.3998 USD |
Purchase |
1,536 |
202.5178 USD |
Purchase |
1,933 |
202.2676 USD |
Purchase |
2,021 |
202.1965 USD |
Purchase |
2,630 |
202.4645 USD |
Purchase |
3,506 |
201.8626 USD |
Purchase |
3,600 |
201.9142 USD |
Purchase |
3,956 |
202.9500 USD |
Purchase |
5,783 |
202.0391 USD |
Purchase |
9,041 |
202.2000 USD |
Purchase |
11,645 |
202.3715 USD |
Purchase |
23,068 |
202.0668 USD |
Sale |
1 |
202.6800 USD |
Sale |
4 |
202.0775 USD |
Sale |
5 |
201.5500 USD |
Sale |
100 |
201.2600 USD |
Sale |
169 |
202.2086 USD |
Sale |
673 |
202.0633 USD |
Sale |
900 |
202.3555 USD |
Sale |
912 |
202.1664 USD |
Sale |
1,086 |
202.1985 USD |
Sale |
1,143 |
201.8894 USD |
Sale |
1,419 |
201.8154 USD |
Sale |
2,080 |
202.2286 USD |
Sale |
2,960 |
201.6533 USD |
Sale |
3,600 |
201.9142 USD |
Sale |
3,990 |
202.9500 USD |
Sale |
4,640 |
202.0760 USD |
Sale |
7,188 |
202.2000 USD |
Sale |
21,278 |
202.0984 USD |
Sale |
21,545 |
202.3499 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing |
| and any other person relating to the voting rights of any relevant securities under any option |
| referred to on this form or relating to the voting rights or future acquisition or disposal of any |
| relevant securities to which any derivative referred to on this form is referenced. If none, this |
| should be stated. |
| NONE |
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 17 Nov 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |